CN104474154A - 治疗感冒发烧的中药剂及制备方法 - Google Patents
治疗感冒发烧的中药剂及制备方法 Download PDFInfo
- Publication number
- CN104474154A CN104474154A CN201410823297.1A CN201410823297A CN104474154A CN 104474154 A CN104474154 A CN 104474154A CN 201410823297 A CN201410823297 A CN 201410823297A CN 104474154 A CN104474154 A CN 104474154A
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- chinese medicine
- boiling
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 145
- 206010037660 Pyrexia Diseases 0.000 title claims abstract description 64
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 238000009835 boiling Methods 0.000 claims description 67
- 241000282326 Felis catus Species 0.000 claims description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 239000007788 liquid Substances 0.000 claims description 35
- 241000628997 Flos Species 0.000 claims description 34
- 235000007164 Oryza sativa Nutrition 0.000 claims description 34
- 235000009566 rice Nutrition 0.000 claims description 34
- 229940079593 drug Drugs 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 24
- 238000010438 heat treatment Methods 0.000 claims description 18
- 241000746375 Andrographis Species 0.000 claims description 14
- 239000012567 medical material Substances 0.000 claims description 13
- 230000008859 change Effects 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 238000003825 pressing Methods 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 10
- 239000006187 pill Substances 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000012467 final product Substances 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 7
- 239000002893 slag Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000000571 coke Substances 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 5
- 235000012907 honey Nutrition 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 241000209094 Oryza Species 0.000 claims 12
- 230000000694 effects Effects 0.000 abstract description 8
- 244000296912 Ageratum conyzoides Species 0.000 abstract description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract description 2
- 244000046146 Pueraria lobata Species 0.000 abstract description 2
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 235000004405 Ageratum conyzoides Nutrition 0.000 abstract 1
- 244000118350 Andrographis paniculata Species 0.000 abstract 1
- 240000003757 Cayratia trifolia Species 0.000 abstract 1
- 244000167230 Lonicera japonica Species 0.000 abstract 1
- 235000017617 Lonicera japonica Nutrition 0.000 abstract 1
- 241000614148 Peucedanum turgeniifolium Species 0.000 abstract 1
- 244000060545 Wikstroemia viridiflora Species 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 240000007594 Oryza sativa Species 0.000 description 22
- 231100000614 poison Toxicity 0.000 description 22
- 239000003440 toxic substance Substances 0.000 description 20
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 206010011224 Cough Diseases 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 206010022000 influenza Diseases 0.000 description 14
- 230000036407 pain Effects 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 230000008961 swelling Effects 0.000 description 12
- 230000036760 body temperature Effects 0.000 description 9
- 238000011084 recovery Methods 0.000 description 9
- 210000000952 spleen Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 239000003172 expectorant agent Substances 0.000 description 8
- 230000003419 expectorant effect Effects 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 206010007247 Carbuncle Diseases 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 244000052769 pathogen Species 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 206010028748 Nasal obstruction Diseases 0.000 description 4
- 206010042674 Swelling Diseases 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000000954 anitussive effect Effects 0.000 description 4
- 229940124584 antitussives Drugs 0.000 description 4
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 4
- 150000002338 glycosides Chemical group 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- -1 monosaccharide glycoside Chemical class 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000004243 sweat Anatomy 0.000 description 4
- 150000008130 triterpenoid saponins Chemical class 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010020741 Hyperpyrexia Diseases 0.000 description 3
- 206010039101 Rhinorrhoea Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 235000015784 Artemisia rupestris Nutrition 0.000 description 2
- 241001670235 Artemisia rupestris Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- 241001310717 Daphne genkwa Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 201000005702 Pertussis Diseases 0.000 description 2
- ZZTYPLSBNNGEIS-OPAXANQDSA-N Pomolic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@](O)(C)[C@H]5C4=CC[C@@H]3[C@]21C ZZTYPLSBNNGEIS-OPAXANQDSA-N 0.000 description 2
- JYEJQUHSBMDABO-SYKQLJDKSA-N Pomolic acid Natural products C[C@@H]1CC[C@@]2(CC[C@H]3[C@@H]4CC[C@H]5C(C)(C)[C@@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2[C@]1(C)O)C(=O)O JYEJQUHSBMDABO-SYKQLJDKSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 208000036071 Rhinorrhea Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011443 conventional therapy Methods 0.000 description 2
- 235000001671 coumarin Nutrition 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229960001680 ibuprofen Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 201000003453 lung abscess Diseases 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- YSCJAYPKBYRXEZ-HZPINHDXSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4ar,6ar,6bs,8as,12as,14ar,14br)-4,4,6a,6b,11,11,14b-heptamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3-hydroxy-4-[(2s,3r,4s, Chemical compound O([C@H]1[C@H](O)[C@H](O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CCC(C[C@H]14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C(O)=O)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O YSCJAYPKBYRXEZ-HZPINHDXSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 240000002930 Alternanthera sessilis Species 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- RKWHWFONKJEUEF-GQUPQBGVSA-O Cyanidin 3-O-glucoside Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 RKWHWFONKJEUEF-GQUPQBGVSA-O 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018286 Gingival pain Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001278898 Glycyrrhiza inflata Species 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000146029 Lindera aggregata Species 0.000 description 1
- 241000195954 Lycopodium clavatum Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- MFIXLWYJTVEVGO-YHGWSDCJSA-N O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(O)=O)[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(O)=O)[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O MFIXLWYJTVEVGO-YHGWSDCJSA-N 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000244269 Peucedanum Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 208000037656 Respiratory Sounds Diseases 0.000 description 1
- 241000725643 Respiratory syncytial virus Species 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241001534930 Thymelaeaceae Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- WCHBFWOEFOZHMK-MLHVESHNSA-N [(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (1r,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-1-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-10-[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-ca Chemical compound O([C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@]1(CC[C@H]([C@@]([C@H]14)(C)O)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1OC[C@H](O)[C@H](O)[C@H]1O WCHBFWOEFOZHMK-MLHVESHNSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000002555 auscultation Methods 0.000 description 1
- 239000010231 banlangen Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- QZHPTGXQGDFGEN-UHFFFAOYSA-N chromene Chemical compound C1=CC=C2C=C[CH]OC2=C1 QZHPTGXQGDFGEN-UHFFFAOYSA-N 0.000 description 1
- YTMNONATNXDQJF-UBNZBFALSA-N chrysanthemin Chemical compound [Cl-].O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC2=C(O)C=C(O)C=C2[O+]=C1C1=CC=C(O)C(O)=C1 YTMNONATNXDQJF-UBNZBFALSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- MFIXLWYJTVEVGO-DNOHTNDQSA-N ilexoside B Natural products C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)C)[C@@H]2[C@]1(C)O)C)C(=O)O MFIXLWYJTVEVGO-DNOHTNDQSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- UZTMYBNYYOCNHL-UHFFFAOYSA-N kakisaponin B Natural products C1CC(C2(CCC3C(C)(CO)C(O)CCC3(C)C2C=C2)C)(C)C2=CC1(CCC(C)C(O)C)C(=O)OC1OC(CO)C(O)C(O)C1O UZTMYBNYYOCNHL-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- WCHBFWOEFOZHMK-UHFFFAOYSA-N oblonganoside H Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC34C)C2C1(C)O)C(=O)OC1OC(CO)C(O)C(O)C1O WCHBFWOEFOZHMK-UHFFFAOYSA-N 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 235000006502 papoula Nutrition 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037833 rales Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000023409 throat pain Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- WFDGBBHAJUVQKE-UHFFFAOYSA-N ziyu-glycoside II Natural products CC1(O)CCCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC34C)C12)C(=O)O WFDGBBHAJUVQKE-UHFFFAOYSA-N 0.000 description 1
- NHWWFKVFYNAGJV-UHFFFAOYSA-N ziyuglycoside I Natural products CC1(O)CCCC2(CCC3(C)C(=CCC4C5(C)CCC(OC6OCC(O)C(O)C6O)C(C)(C)C5CCC34C)C12)C(=O)OC7OC(CO)C(O)C(O)C7O NHWWFKVFYNAGJV-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗感冒发烧的中药剂及其制备方法,取下述重量配比的主要原料药制备而成:节节花15-30,白前8-16,葛根15-20,地榆9-15,母猪藤根6-10,了哥王5-12,胜红蓟8-14,穿心莲9-15,地皮消4-8,金银花10-20,长前胡6-9,甘草8-12。发明提供的治疗感冒发烧的中药剂疗效快、安全、无毒副作用、标本兼治。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种治疗感冒发烧的中药剂及其制备方法。
背景技术
感冒发烧是指感冒常常能引起发烧症状,感冒的发生主要由于体虚,抗病能力减弱而引起的。当气候剧变时,人体内外功能不能适应,邪气乘虚由皮毛、口鼻而入,引起一系列发热症状。发热是指致热原直接作用于体温调节中枢,体温中枢功能紊乱或各种原因引起的产热过多、散热减少,导致体温升高超过正常范围的情形。感冒在中医临床上分为风寒、风热、暑湿、表寒里热等型。风寒感冒:主要表现为鼻塞声重、打喷嚏、流清鼻涕、咳嗽、痰白稀、头痛、头晕、厌食等,怕寒明显,全身无汗且有酸痛不适的感觉,一般不发热,即使有发热也比较轻。风热感冒:主要表现为流黄黏稠鼻涕,发热明显,甚至有高热、出汗、咽喉痛、咳嗽、痰黄稠,舌苔呈薄黄色。暑湿感冒:主要表现为发热、头昏、浑身胀痛、身体倦怠伴有胸闷、恶心等症。表寒里热感冒:又名“寒包火”,多以恶寒发热、咳嗽气喘、痰黄黏稠、烦躁、头痛为主症。对于风寒感冒,应该用辛温的解表药以宣肺散寒,对于风热感冒应该使用辛凉的解表药物,对于暑湿感冒则应该用清暑祛湿解表的药物。
感冒是一种常见的疾病,感冒约有70%是由感染病毒引起的,主要有流感病毒(甲、乙、丙)、副流感病毒、呼吸道合胞病毒、腺病毒、鼻病毒、埃可病毒、柯萨奇病毒、麻疹病毒、风疹病毒。一般在受到感染后1-3天便会出现鼻塞、喷嚏、流鼻涕、咽部不适、轻咳、发热等,热度高低不一。对于感冒发烧的治疗,主要是对症处理,建议在感冒引起发烧后体温超过38.5℃后用药,常用迪尔诺布洛芬混悬液,其中的布洛芬成分有解热镇痛作用,非甾体抗炎药,为环氧化酶抑制剂,常规剂量副作用少,用于缓解普通感冒及流行性感冒引起的发热、头痛、四肢酸痛、打喷嚏、流鼻涕、鼻塞、咽痛等症状。
申请公布号 CN 102370810 A(申请号 201110198814.7)的中国专利文献公开了一种复方一枝蒿胶囊及其制备方法。该发明所述的一种复方一枝蒿胶囊,由下述中药原料制成:一枝蒿、板蓝根、大青叶。公开号CN 103316063A(申请号201210444851.6)的中国专利文献公开了一种退高烧的草药。成人感冒发烧,取鲜青蒿500g压汁喝,高烧会退下。幼儿可根据年龄和体重酌情增减。秋冬二季没有青蒿,可用莲子芯退高烧。公开号CN 101411834A(申请号200810237655.5的中国专利文献公开了一种治疗感冒发烧的中药药剂,组成为桔梗、黄连、黄芩、冬瓜仁、苡仁、鱼腥草、桃仁、甘草。
传统治疗多为西药如阿司匹林、对乙酰氨基酚等,其治疗只是发汗解热、抗病毒,不能从根本上清除内热。单纯用西药退烧只是缓解症状,并没有从根本上治疗感冒。用酒精擦抹全身等方法退烧是寒性的,攻伐正气,用多了后患无穷。滥用抗生素退烧,实际上是破坏了人体免疫力,使免疫系统无法抵御外邪,使病气深入加重。表面症状虽然暂时消失,但不久必然出现更严重的内脏功能失常症状。
发明内容
针对现有技术的不足,本发明的目的是提供一种治疗感冒发烧的中药剂及其制备方法。本发明提供的治疗感冒发烧的中药剂疗效快、安全、无毒副作用、标本兼治。
本发明的技术方案是:
治疗感冒发烧的中药剂,取下述重量配比的主要原料药制备而成:节节花 15-30,白前8-16,葛根15-20,地榆9-15,母猪藤根6-10,了哥王5-12,胜红蓟8-14,穿心莲9-15,地皮消4-8,金银花10-20,长前胡6-9,甘草8-12。
治疗感冒发烧的中药剂,优选的方案是,取下述重量配比的主要原料药制备而成:节节花 19-25,白前10-14,葛根16-19,地榆10-13,母猪藤根7-9,了哥王7-10,胜红蓟9-12,穿心莲10-13,地皮消5-7,金银花14-18,长前胡6.5-8,甘草9-11。
治疗感冒发烧的中药剂,更加优选的方案是,取下述重量配比的主要原料药制备而成:节节花 22,白前13,葛根17,地榆11,母猪藤根8,了哥王9,胜红蓟10,穿心莲11,地皮消6,金银花16,长前胡7,甘草10。
本发明还提供了将前述治疗感冒发烧的中药剂制成药学上可接受的丸剂、稠膏剂、散剂和汤剂的制备方法。
所述丸剂的制备方法是:
(1)先将锅烧热,撒上浸湿的大米,使其平贴锅上,加热至大米冒烟时投入了哥王,大米的重量为了哥王重量的1/3-1/2(优选大米的重量为了哥王重量的2/5),轻轻翻动,炒至大米呈焦黄色取出,去大米,将了哥王放凉,研成细粉,过120-140目筛(优选过130目筛);
(2)将金银花研成细粉,过120-140目筛(优选过130目筛);
(3)将母猪藤根放入砂锅中,加水,加水量为母猪藤根重量的3-6倍(优选加水量为母猪藤根重量的4.5倍),先用武火煎煮至沸腾,后转文火煎煮50-65分钟(优选后转文火煎煮55分钟),滤出药液,静置7-9小时(优选静置8小时),得滤液;
(4)将除了哥王、母猪藤根和金银花外的其余9味药材共研细末,过120-140目筛(优选过130目筛);
(5)将步骤(1)、步骤(2)和步骤(4)所得细粉充分混匀,用步骤(3)所得滤液泛丸,制得的每丸的重量为0.15-0.4g(优选制得的每丸的重量为0.2g),在65-75℃的温度下干燥(优选在68℃的温度下干燥),使丸剂含水量控制在8%以内,即得。
所述稠膏剂的制备方法是:
(1)将除金银花外的其余11味中药材倒入药锅内摊平,然后加水浸泡5-7小时(优选然后加水浸泡6小时),轻压药材时水高出药平面约8-10厘米(优选轻压药材时水高出药平面约9厘米);
(2)将步骤(1)浸泡过的药材先用武火煎煮至沸腾,后转文火煎煮1.3-2.2小时(优选后转文火煎煮1.8小时),滤出药液后,重新加水至高出药平面约6-8厘米(优选重新加水至高出药平面约7厘米),继续武火煎煮至沸腾后改为文火煎煮1-1.6小时(优选继续武火煎煮至沸腾后改为文火煎煮1.3小时),加入金银花,煎沸15-25分钟(优选煎沸20分钟),趁热将药液滤出后,将药渣用双层纱布包好,绞取药渣内剩余药液;
(3)合并三次药液,静置7-10小时后(优选静置9小时后),取上清液加热浓缩成相对密度为1.28-1.35的稠膏状药物(优选取上清液加热浓缩成相对密度为1.32的稠膏状药物);
(4)取步骤(3)所得稠膏状药物1.5-2.2倍量的炼蜜加入到稠膏状药物中(优选取步骤(3)所得稠膏状药物2倍量的炼蜜加入到稠膏状药物中),搅拌均匀,分装在洁净干燥灭菌的容器中,待充分冷却后加盖密闭即可。
所述散剂的制备方法是:
(1)先将锅烧热,撒上浸湿的大米,使其平贴锅上,加热至大米冒烟时投入了哥王,大米的重量为了哥王重量的1/3-1/2(优选大米的重量为了哥王重量的2/5),轻轻翻动,炒至大米呈焦黄色取出,去大米,将了哥王放凉,研成细粉;
(2)将母猪藤根放入砂锅中,加水,加水量为母猪藤根重量的3.5-6.5倍(优选加水量为母猪藤根重量的5倍),先用武火煎煮至沸腾,后转文火煎煮55-70分钟(优选后转文火煎煮60分钟),滤出药液,静置7-9小时(优选静置8小时),取上清液加热浓缩成相对密度为1.32-1.38的稠膏状药物(优选取上清液加热浓缩成相对密度为1.35的稠膏状药物);
(3)将除了哥王和母猪藤根外的其余10味药材分别研成细末;
(4)加乙醇与步骤(2)所得稠膏状药物共研,再加入步骤(1)和步骤(3)所得细粉研匀,干燥即得。
所述汤剂的制备方法是:
(1)将除金银花外的其余11味中药材倒入药锅内摊平,然后加水浸泡50-80分钟(优选然后加水浸泡65分钟),轻压药材时水高出药平面约1.8-2.5厘米(优选轻压药材时水高出药平面约2.3厘米);
(2)将步骤(1)浸泡过的药材先用武火煎煮至沸腾,后转文火煎煮30-45分钟(优选后转文火煎煮40分钟),滤出药液后,重新加水至高出药平面约0.8-1.5厘米(优选重新加水至高出药平面约1.3厘米),继续武火煎煮至沸腾后改为文火煎煮20-30分钟(优选继续武火煎煮至沸腾后改为文火煎煮25分钟),加入金银花,煎沸8-14分钟(优选煎沸12分钟),趁热将药液滤出后,将药渣用双层纱布包好,绞取药渣内剩余药液;
(3)合并三次药液即得。
本发明提供的治疗感冒发烧的中药剂选用价廉易得的中草药为主要原料,配伍科学合理。除此之外,本发明的优良效果还表现在:
1、解表祛邪,让邪气退出机体,则不治烧而烧自退,标本同治,故能速愈感冒;
2、安全、无毒副作用;
3、具有清热解毒、下痰止嗽、解肌退热、宜散风热、散瘀消肿、补脾益气等功效,
对于治疗感冒发烧效果显著;
4、制备方法简单,服用方便。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
本发明所用主要中药原料的药理如下:
节节花:基原:为苋科植物莲子草的全草。药性:甘,寒。归心、胃、小肠经。功用主治:凉血散瘀,清热解毒,除湿通淋。主咳血,吐血,便血,湿热黄疸,痢疾,泄泻,牙龈肿痛,咽喉肿痛,肠痈,乳痈,痒腮,痈疽肿毒,湿疹,淋症,跌打损伤,毒蛇咬伤。
白前:基原:为萝藦科植物柳叶白前或芫花叶白前的根及根茎。化学成份:含三萜皂甙、海罂栗甙元A、B、海罂粟甙A及海罂粟甙元C-黄花夹竹桃单糖甙等。芫花叶白前含三萜皂甙。药性:辛、甘,微温。归肺经。功用主治:泻肺降气,下痰止嗽。治肺实喘满,咳嗽,多痰,胃脘疼痛。
葛根:基原:为豆科植物野葛的干燥根。习称野葛。干燥。药性:甘、辛,凉。归脾、胃经。功用主治:解肌退热,生津,透疹,升阳止泻。用于外感发热头痛、项背强痛,口渴,消渴,麻疹不透,热痢,泄泻,高血压颈项强痛。
地榆:基原:为蔷薇种植物地榆的根及根茎。化学成份:根含鞣质约17%,三萜皂甙2.5~4.0%。分离出的皂甙有:地榆糖甙I,水解后产生坡模醇酸、阿拉伯糖和葡萄糖,地榆糖甙Ⅱ,水解后产生坡模醇酸和阿拉伯糖,地柿皂甙B,初步鉴定是葡萄糖醛酸的三萜皂甙。茎叶含槲皮素和山柰酚的甙,熊果酸等三萜类物质。叶含维生素C。花含矢车菊甙、矢车菊双甙压作用。药性:苦酸,寒。归肝、大肠经。功用主治:凉血止血,清热解毒。治吐血,衄血,血痢,崩漏,肠风,痔漏,痈肿,湿疹,金疮,烧伤。
母猪藤根:基原:为葡萄科植物母猪藤的根。药性:辛,凉,有毒。归肺、脾经。功用主治:清热解毒。主肺痈,疮疖。
了哥王:基原:为瑞香科植物了哥王的茎叶。药性:苦、辛,寒,有毒。归心、肺、小肠经。功用主治:清热解毒,消肿散结,止痛。治瘰疬,痈肿,风湿痛,百日咳,跌打损伤。
胜红蓟:基原:为菊科胜红蓟属植物藿香蓟的全草。成分:全草含多种黄酮类化合物:胜红蓟黄酮A、B、C,川陈皮素,甜橙素,钓樟黄铜B等。全草还含有生物碱:石松胺,刺凌备草碱及三萜类化合物:无羁萜,甾醇类:豆甾醇等。挥发油:胜红蓟色烯,香豆精等。地上部分含有多种色烯类化合物:7-甲氧基-2,2-二甲基色原烯,7,8-二甲氧基-2,2-二甲基色原烯等。药性:微苦、辛,凉。归肺、心包经。功用主治:清热解毒,止血,止痛。主治感冒发热,咽喉肿痛,口舌生疮,咯血,衄血,崩漏,脘腹疼痛,风湿痹痛,跌打损伤,外伤出血,鹅口疮,痈肿疔疮,湿疹瘙痒。
穿心莲:基原:为爵床科植物穿心莲的全草或叶。药性:《泉州本草》:“味苦,性寒,无毒。”《泉州本草》:“入心、肺二经。”功用主治:清热解毒,凉血消肿。治急性菌痢,胃肠炎,感冒,流脑,气管炎,肺炎,百日咳,肺结核,肺脓疡,胆囊炎,高血压,鼻衄,口咽肿痛,疮疖痈肿,水火烫伤,毒蛇咬伤。
地皮消:基原:为爵床科植物地皮消的全草。药性:味微苦,辛,性凉。功用主治: 清热解毒,散瘀消肿。主肺热咳嗽,咽喉肿痛,痄腮,瘰疬,痈肿疮毒,跌打骨折,外伤感染。
金银花:基原:为忍冬科植物忍冬的花蕾。化学成份:花含木犀草素、肌醇约1%及皂甙、鞣质等。药性:甘,寒。归肺、胃经。功用主治:清热,解毒。治温病发热,热毒血痢,痈疡,肿毒,瘰疬,痔漏。
长前胡:基原:为伞形科前胡属植物长前胡的根。成分:全草含香豆素类,包括长前胡甲素、长前胡乙素、长前胡丙素、顺式消旋凯诺内酯、反式消旋凯诺内酯等。药性:性微寒,味辛、苦,无毒。归肺、脾耳二经。功用主治:宜散风热,祛痰镇咳,下气。用于感冒风热,咳嗽痰稠,喘满,头痛及胸闷。
甘草:基原:为豆科植物甘草、胀果甘草或光果甘草的干燥根及根茎。药性:甘,平。归心、肺、脾、胃经。功用主治:补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,院腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。
实施例1治疗感冒发烧的中药剂,取下述重量份的主要原料药制备而成(每份为50g):节节花 15份,白前8份,葛根15份,地榆9份,母猪藤根6份,了哥王5份,胜红蓟8份,穿心莲9份,地皮消4份,金银花10份,长前胡6份,甘草8份。
上述治疗感冒发烧的中药剂汤剂的制备方法是:
(1)将除金银花外的其余11味中药材倒入药锅内摊平,然后加水浸泡50分钟,轻压药材时水高出药平面约1.8厘米;
(2)将步骤(1)浸泡过的药材先用武火煎煮至沸腾,后转文火煎煮30分钟,滤出药液后,重新加水至高出药平面约0.8厘米,继续武火煎煮至沸腾后改为文火煎煮20分钟,加入金银花,煎沸8分钟,趁热将药液滤出后,将药渣用双层纱布包好,绞取药渣内剩余药液;
(3)合并三次药液即得。
本发明治疗感冒发烧的中药剂汤剂的使用方法:口服,每日两次,每次200mL(温热)。
实施例2治疗感冒发烧的中药剂,取下述重量份的主要原料药制备而成(每份为50g):节节花 30份,白前16份,葛根20份,地榆15份,母猪藤根10份,了哥王12份,胜红蓟14份,穿心莲15份,地皮消8份,金银花20份,长前胡9份,甘草12份。
上述治疗感冒发烧的中药剂丸剂的制备方法是:
(1)先将锅烧热,撒上浸湿的大米,使其平贴锅上,加热至大米冒烟时投入了哥王,大米的重量为了哥王重量的2/5,轻轻翻动,炒至大米呈焦黄色取出,去大米,将了哥王放凉,研成细粉,过130目筛;
(2)将金银花研成细粉,过130目筛;
(3)将母猪藤根放入砂锅中,加水,加水量为母猪藤根重量的4.5倍,先用武火煎煮至沸腾,后转文火煎煮55分钟,滤出药液,静置8小时,得滤液;
(4)将除了哥王、母猪藤根和金银花外的其余9味药材共研细末,过130目筛;
(5)将步骤(1)、步骤(2)和步骤(4)所得细粉充分混匀,用步骤(3)所得滤液泛丸,制得的每丸的重量为0.2g,在68℃的温度下干燥,使丸剂含水量控制在8%以内,即得。
典型病例一:刘XX,男,28岁。主诉:感冒发烧无汗,咳嗽,食欲差,有困睡感,输液两天,无好转。查:T:38.9℃。服用本实施例所得治疗感冒发烧的中药剂丸剂,口服,每日三次,每次20丸。服用1天,烧退。服用三天,诸症消失,痊愈。
实施例3治疗感冒发烧的中药剂,取下述重量份的主要原料药制备而成(每份为50g):节节花 19份,白前10份,葛根16份,地榆10份,母猪藤根7份,了哥王7份,胜红蓟9份,穿心莲10份,地皮消5份,金银花14份,长前胡6.5份,甘草9份。
上述治疗感冒发烧的中药剂稠膏剂的制备方法是:
(1)将除金银花外的其余11味中药材倒入药锅内摊平,然后加水浸泡6小时,轻压药材时水高出药平面约9厘米;
(2)将步骤(1)浸泡过的药材先用武火煎煮至沸腾,后转文火煎煮1.8小时,滤出药液后,重新加水至高出药平面约7厘米,继续武火煎煮至沸腾后改为文火煎煮1.3小时,加入金银花,煎沸20分钟,趁热将药液滤出后,将药渣用双层纱布包好,绞取药渣内剩余药液;
(3)合并三次药液,静置9小时后,取上清液加热浓缩成相对密度为1.32的稠膏状药物;
(4)取步骤(3)所得稠膏状药物2倍量的炼蜜加入到稠膏状药物中,搅拌均匀,分装在洁净干燥灭菌的容器中,待充分冷却后加盖密闭即可。
典型病例二:林XX,女,34岁。主诉:头痛,身上冷2天余。口服感冒通和伤风胶囊两天。服药后缓解停药后就又发烧。发病以来无鼻塞流涕,无咳嗽病史。查体吸气时胸痛,夜晚体温较高。4天前着凉病史。体温38.5℃,血压120、80毫米汞柱。初步诊断感冒。服用本实施例所得治疗感冒发烧的中药剂稠膏剂,口服,每日两次,每次15g。服用两次,体温恢复至正常值。服用3天,诸症消失,痊愈。
实施例4治疗感冒发烧的中药剂,取下述重量份的主要原料药制备而成(每份为50g):节节花 25份,白前14份,葛根19份,地榆13份,母猪藤根9份,了哥王10份,胜红蓟12份,穿心莲13份,地皮消7份,金银花18份,长前胡8份,甘草11份。
上述治疗感冒发烧的中药剂散剂的制备方法是:
(1)先将锅烧热,撒上浸湿的大米,使其平贴锅上,加热至大米冒烟时投入了哥王,大米的重量为了哥王重量的2/5,轻轻翻动,炒至大米呈焦黄色取出,去大米,将了哥王放凉,研成细粉;
(2)将母猪藤根放入砂锅中,加水,加水量为母猪藤根重量的5倍,先用武火煎煮至沸腾,后转文火煎煮60分钟,滤出药液,静置8小时,取上清液加热浓缩成相对密度为1.35的稠膏状药物;
(3)将除了哥王和母猪藤根外的其余10味药材分别研成细末;
(4)加乙醇与步骤(2)所得稠膏状药物共研,再加入步骤(1)和步骤(3)所得细粉研匀,干燥即得。
典型病例三:陈XX,女,48岁。主诉:咳嗽、咳痰、高热、乏力2日。查体:神清、气稍促,心律95bpm,律齐,体温39.1℃,血压110/70mmHg。心扉听诊:两肺呼吸音粗,未及明显啰音。发病来胃纳差、精神欠佳、二便可、夜眠可。诊断:急性上呼吸道感染。中医感冒。服用本实施例所得治疗感冒发烧的中药剂散剂,每日两次,每次0.5g,开水冲服。服用两次,体温降至正常值。服用4天,诸症消失,痊愈。
实施例5治疗感冒发烧的中药剂,取下述重量份的主要原料药制备而成(每份为50g):节节花 22份,白前13份,葛根17份,地榆11份,母猪藤根8份,了哥王9份,胜红蓟10份,穿心莲11份,地皮消6份,金银花16份,长前胡7份,甘草10份。
上述治疗感冒发烧的中药剂汤剂的制备方法是:
(1)将除金银花外的其余11味中药材倒入药锅内摊平,然后加水浸泡65分钟,轻压药材时水高出药平面约2.3厘米;
(2)将步骤(1)浸泡过的药材先用武火煎煮至沸腾,后转文火煎煮40分钟,滤出药液后,重新加水至高出药平面约1.3厘米,继续武火煎煮至沸腾后改为文火煎煮25分钟,加入金银花,煎沸12分钟,趁热将药液滤出后,将药渣用双层纱布包好,绞取药渣内剩余药液;
(3)合并三次药液即得。
试验例:为了验证实施例5所得治疗感冒发烧的中药剂汤剂的药效,我们进行了对比试验。2009年3月-2011年5月,在8所医院筛选258例感冒发烧患者,其中男性100例,女性158例,年龄15-60岁,平均年龄30.5岁,病程1-5d,平均病程2.5d。随机分为两组,实验组和对照组(每组129人)。实验组男性49例,女性80例,年龄15-60岁,平均年龄30.5岁,病程1-5d,平均病程2.5d。对照组男性51例,女性78例,年龄15-60岁,平均年龄30.5岁,病程1-5d,平均病程2.5d。实验组使用本实施例5所得产品,使用方法:口服,每日两次,每次200mL(温热)。对照组使用常规治疗感冒发烧的药物(如阿斯匹林、感冒通片、六神丸等)。疗效情况判定标准:临床痊愈:治疗3d以内体温恢复正常,感冒症状全部消失;显效:治疗3d以内体温正常,感冒大全部症状消失;好转:治疗3d以内体温较以前降低,感冒的主要症状部分消失;无效:治疗3d以内体温未降或升高,感冒的主要症状无改善。其中总有效包括临床痊愈和显效。结果如表1所示。
表1表1:实施例5所得治疗感冒发烧的中药剂汤剂效果验证
疗效分析:从表1可以看出,使用实施例5所得治疗感冒发烧的中药剂汤剂的实验组的临床痊愈率高达80.62%,总有效率达到了98.45%,而使用常规治疗感冒发烧药物的临床痊愈率只有48.84%。实验表明,使用实施例5所得治疗感冒发烧的中药剂汤剂的与使用其他治疗感冒发烧药物的相比,其疗效大幅度提高,而且痊愈率显著提升,并且无效率显著降低。
本发明选择节节花、白前、葛根和地榆等进行配伍,制成治疗感冒发烧的中药剂。方中节节花凉血散瘀,清热解毒,除湿通淋。白前泻肺降气,下痰止嗽。葛根解肌退热,生津,透疹,升阳止泻。地榆凉血止血,清热解毒。母猪藤根清热解毒。了哥王清热解毒,消肿散结,止痛。胜红蓟清热解毒,止血,止痛。穿心莲清热解毒,凉血消肿。地皮消清热解毒,散瘀消肿。金银花清热,解毒。长前胡宜散风热,祛痰镇咳,下气。甘草补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药。诸药合用,具有清热解毒、下痰止嗽、解肌退热、宜散风热、散瘀消肿、补脾益气等功效,解表祛邪,让邪气退出机体,则不治烧而烧自退,标本同治,故能速愈感冒。
最后应说明的是,实施例只是本发明最优的具体实施方式而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (10)
1.治疗感冒发烧的中药剂,其特征在于,取下述重量配比的主要原料药制备而成:节节花 15-30,白前8-16,葛根15-20,地榆9-15,母猪藤根6-10,了哥王5-12,胜红蓟8-14,穿心莲9-15,地皮消4-8,金银花10-20,长前胡6-9,甘草8-12。
2.如权利要求1所述的治疗感冒发烧的中药剂,其特征在于,取下述重量配比的主要原料药制备而成:节节花 19-25,白前10-14,葛根16-19,地榆10-13,母猪藤根7-9,了哥王7-10,胜红蓟9-12,穿心莲10-13,地皮消5-7,金银花14-18,长前胡6.5-8,甘草9-11。
3.如权利要求1所述的治疗感冒发烧的中药剂,其特征在于,取下述重量配比的主要原料药制备而成:节节花 22,白前13,葛根17,地榆11,母猪藤根8,了哥王9,胜红蓟10,穿心莲11,地皮消6,金银花16,长前胡7,甘草10。
4.如权利要求1~3任一所述的治疗感冒发烧的中药剂,其特征在于,将该治疗感冒发烧的中药剂制成药学上可接受的丸剂,所述丸剂的制备方法是:
(1)先将锅烧热,撒上浸湿的大米,使其平贴锅上,加热至大米冒烟时投入了哥王,大米的重量为了哥王重量的1/3-1/2(优选大米的重量为了哥王重量的2/5),轻轻翻动,炒至大米呈焦黄色取出,去大米,将了哥王放凉,研成细粉,过120-140目筛(优选过130目筛);
(2)将金银花研成细粉,过120-140目筛(优选过130目筛);
(3)将母猪藤根放入砂锅中,加水,加水量为母猪藤根重量的3-6倍(优选加水量为母猪藤根重量的4.5倍),先用武火煎煮至沸腾,后转文火煎煮50-65分钟(优选后转文火煎煮55分钟),滤出药液,静置7-9小时(优选静置8小时),得滤液;
(4)将除了哥王、母猪藤根和金银花外的其余9味药材共研细末,过120-140目筛(优选过130目筛);
(5)将步骤(1)、步骤(2)和步骤(4)所得细粉充分混匀,用步骤(3)所得滤液泛丸,制得的每丸的重量为0.15-0.4g(优选制得的每丸的重量为0.2g),在65-75℃的温度下干燥(优选在68℃的温度下干燥),使丸剂含水量控制在8%以内,即得。
5.如权利要求1~3任一所述的治疗感冒发烧的中药剂,其特征在于,将该治疗感冒发烧的中药剂制成药学上可接受的稠膏剂,所述稠膏剂的制备方法是:
(1)将除金银花外的其余11味中药材倒入药锅内摊平,然后加水浸泡5-7小时(优选然后加水浸泡6小时),轻压药材时水高出药平面约8-10厘米(优选轻压药材时水高出药平面约9厘米);
(2)将步骤(1)浸泡过的药材先用武火煎煮至沸腾,后转文火煎煮1.3-2.2小时(优选后转文火煎煮1.8小时),滤出药液后,重新加水至高出药平面约6-8厘米(优选重新加水至高出药平面约7厘米),继续武火煎煮至沸腾后改为文火煎煮1-1.6小时(优选继续武火煎煮至沸腾后改为文火煎煮1.3小时),加入金银花,煎沸15-25分钟(优选煎沸20分钟),趁热将药液滤出后,将药渣用双层纱布包好,绞取药渣内剩余药液;
(3)合并三次药液,静置7-10小时后(优选静置9小时后),取上清液加热浓缩成相对密度为1.28-1.35的稠膏状药物(优选取上清液加热浓缩成相对密度为1.32的稠膏状药物);
(4)取步骤(3)所得稠膏状药物1.5-2.2倍量的炼蜜加入到稠膏状药物中(优选取步骤(3)所得稠膏状药物2倍量的炼蜜加入到稠膏状药物中),搅拌均匀,分装在洁净干燥灭菌的容器中,待充分冷却后加盖密闭即可。
6.如权利要求1~3任一所述的治疗感冒发烧的中药剂,其特征在于,将该治疗感冒发烧的中药剂制成药学上可接受的散剂,所述散剂的制备方法是:
(1)先将锅烧热,撒上浸湿的大米,使其平贴锅上,加热至大米冒烟时投入了哥王,大米的重量为了哥王重量的1/3-1/2(优选大米的重量为了哥王重量的2/5),轻轻翻动,炒至大米呈焦黄色取出,去大米,将了哥王放凉,研成细粉;
(2)将母猪藤根放入砂锅中,加水,加水量为母猪藤根重量的3.5-6.5倍(优选加水量为母猪藤根重量的5倍),先用武火煎煮至沸腾,后转文火煎煮55-70分钟(优选后转文火煎煮60分钟),滤出药液,静置7-9小时(优选静置8小时),取上清液加热浓缩成相对密度为1.32-1.38的稠膏状药物(优选取上清液加热浓缩成相对密度为1.35的稠膏状药物);
(3)将除了哥王和母猪藤根外的其余10味药材分别研成细末;
(4)加乙醇与步骤(2)所得稠膏状药物共研,再加入步骤(1)和步骤(3)所得细粉研匀,干燥即得。
7.如权利要求1~3任一所述的治疗感冒发烧的中药剂,其特征在于,将该治疗感冒发烧的中药剂制成药学上可接受的汤剂,所述汤剂的制备方法是:
(1)将除金银花外的其余11味中药材倒入药锅内摊平,然后加水浸泡50-80分钟,轻压药材时水高出药平面约1.8-2.5厘米;
(2)将步骤(1)浸泡过的药材先用武火煎煮至沸腾,后转文火煎煮30-45分钟(优选后转文火煎煮40分钟),滤出药液后,重新加水至高出药平面约0.8-1.5厘米,继续武火煎煮至沸腾后改为文火煎煮20-30分钟(优选继续武火煎煮至沸腾后改为文火煎煮25分钟),加入金银花,煎沸8-14分钟(优选煎沸12分钟),趁热将药液滤出后,将药渣用双层纱布包好,绞取药渣内剩余药液;
(3)合并三次药液即得。
8.如权利要求7所述的治疗感冒发烧的中药剂汤剂的制备方法,其特征在于,步骤(1)中然后加水浸泡65分钟。
9.如权利要求7所述的治疗感冒发烧的中药剂汤剂的制备方法,其特征在于,步骤(1)中轻压药材时水高出药平面约2.3厘米。
10.如权利要求7所述的治疗感冒发烧的中药剂汤剂的制备方法,其特征在于,步骤(2)中重新加水至高出药平面约1.3厘米。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410823297.1A CN104474154A (zh) | 2014-12-26 | 2014-12-26 | 治疗感冒发烧的中药剂及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410823297.1A CN104474154A (zh) | 2014-12-26 | 2014-12-26 | 治疗感冒发烧的中药剂及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104474154A true CN104474154A (zh) | 2015-04-01 |
Family
ID=52748855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410823297.1A Pending CN104474154A (zh) | 2014-12-26 | 2014-12-26 | 治疗感冒发烧的中药剂及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104474154A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108434236A (zh) * | 2018-04-28 | 2018-08-24 | 陆垚西 | 一种用于治疗感冒发烧的中药组合物 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1600352A (zh) * | 2003-09-25 | 2005-03-30 | 杭州健源生物技术有限公司 | 一种治疗感冒的中药组合物及制备方法 |
| CN101337021A (zh) * | 2008-06-02 | 2009-01-07 | 王跃进 | 双胡连热毒清颗粒 |
| CN102397338A (zh) * | 2010-09-16 | 2012-04-04 | 上海玉森新药开发有限公司 | 一种治疗流行性感冒的中药组合物 |
-
2014
- 2014-12-26 CN CN201410823297.1A patent/CN104474154A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1600352A (zh) * | 2003-09-25 | 2005-03-30 | 杭州健源生物技术有限公司 | 一种治疗感冒的中药组合物及制备方法 |
| CN101337021A (zh) * | 2008-06-02 | 2009-01-07 | 王跃进 | 双胡连热毒清颗粒 |
| CN102397338A (zh) * | 2010-09-16 | 2012-04-04 | 上海玉森新药开发有限公司 | 一种治疗流行性感冒的中药组合物 |
Non-Patent Citations (3)
| Title |
|---|
| 王成阳等: ""感冒中医药诊治最新研究进展"", 《辽宁中医药大学学报》 * |
| 赵国东: "《新编家庭医生百科大全》", 31 January 2014, 湖北科学技术出版社 * |
| 赵静等: ""中医药治疗流行性感冒文本挖掘结果与诊疗方案的比较分析"", 《中医杂志》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108434236A (zh) * | 2018-04-28 | 2018-08-24 | 陆垚西 | 一种用于治疗感冒发烧的中药组合物 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102973801A (zh) | 治疗慢性咽炎或扁桃体炎的中药组合物及其制备方法 | |
| CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
| CN104173980A (zh) | 流感清热解表的中药组合物及制备方法 | |
| CN101181393A (zh) | 治疗感冒的中药制剂及其生产方法 | |
| CN104147572A (zh) | 感冒发热疏风散热制剂及制备方法 | |
| CN104147574A (zh) | 治疗感冒发烧的清热解表中药组合物及制备方法 | |
| CN104173978A (zh) | 治疗冬季感冒高烧清热散寒的中药组合物及制备方法 | |
| CN104474154A (zh) | 治疗感冒发烧的中药剂及制备方法 | |
| CN104173979A (zh) | 感冒咳嗽清热散寒的中药组合物及制备方法 | |
| CN105343344A (zh) | 治疗矽肺的滋阴养肺方剂及制备方法 | |
| CN105381291A (zh) | 一种预治肺炎的中药组合物及其制备方法和应用 | |
| CN105125786A (zh) | 一种用于治疗乳腺增生的中药制剂及制备方法 | |
| CN104435410A (zh) | 治疗风寒感冒的中药剂及制备方法 | |
| CN105687779A (zh) | 一种止咳喘颗粒及其制备方法 | |
| CN105796951A (zh) | 放射科用于治疗鼻息肉的外用制剂及制法 | |
| CN104707003B (zh) | 治疗高血压、高血脂的中药胶囊 | |
| CN104042872A (zh) | 治疗小儿感冒的中药组合物及其制备方法 | |
| CN106237060A (zh) | 一种用于治疗慢性支气管炎的中药胶囊 | |
| CN105343234A (zh) | 一种预防或治疗小儿流感的糖丸及其制备方法 | |
| CN106309889A (zh) | 一种用于治疗慢性支气管炎的中药汤剂 | |
| CN104771551A (zh) | 一种治疗咽炎和鼻窦炎并发的中药喷雾剂及制法 | |
| CN105963454A (zh) | 一种用于治疗乳腺增生的中药制剂及制备方法 | |
| CN106692883A (zh) | 一种治疗白喉的药物及其制备方法 | |
| CN105168495A (zh) | 治疗荨麻疹的中药药浴的制备方法 | |
| CN106039082A (zh) | 一种治疗鼻炎的药物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 628000 Sichuan City, Guangyuan Province Li District, Nanjing Road, No. 32 Fuson District, building 1-501, No. 2 Applicant after: Ma Sidong Address before: Licheng District 250000 Shandong city of Ji'nan province Huashan Jia Zhuang Zhen Shan Gen Zhi Applicant before: Ma Sidong |
|
| COR | Change of bibliographic data | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |